经常在坛子里找到各种资料，所以我也回馈一个，花旗关于国内医疗健康产业的分析报告，从医药到器械都有介绍，163页，免费送给大家，欢迎大家下载。

China Healthcare Sector  Handbook Dec-2010: Identifying the Long-Term Leaders

Contents
National Health Expenses (NHE)  5
Government Spending Driving Growth in National Health
Expenses  6  
Central vs. Provincial Government Spending on NHE  7  
Medical Expenses and Costs of Hospital Visits  8
Drug Costs Are a Key Component of Hospital Visits  9  
Hospital System  10
Increase in Investments in Private Hospitals  11
Government Is Upgrading the Hospital System  12
Physicians and Nurses (Health Pr ofessionals) Are Clustered in
Government-Owned Hospitals  13
Hospital Traffic Largely Biased Towards Large Hospitals  14
Hospital Traffic Largely Biased Towards Large Hospitals (cont’d)  15
Hospital Visits Have Increased, Driven by Improved Healthcare
Coverage  16
Overall View of Medical Coverage Program  17
Medical Coverage Penetration Is High, but Payout to New Rural
Cooperative Program Is Low  18
Medical Insurance Fund Payout Will Increase  19
Demographic Shift  20
China’s Population Is Aging  20
Top 10 Causes of Death in China  21
Increasing Incidence of Tumors  22
Increase in Death Rate from Tumors  23
Increasing Incidence of Chronic Circulatory Diseases and Death
Rate of Cardiovascular Diseases  24
sFDA’s Shift of Approval  Standards Toward New Drugs  25
Analysis of China’s Pharmaceutical Market  26
China’s Hospital Drug Market  27
Analysis of Market for Essential Drug List (EDL)  28
Traditional Chinese Medicine (TCM) Market  29
Detailed Analysis of Therapeutic Drugs  31
Top 20 Drug Companies Based on Analysis of Prescription Data
from 420 hospitals in 22 Major Cities  34
Top 20 Hospital Drugs Based on  Analysis of Prescription Data
from 420 hospitals in 22 Major Cities  35
Top Therapeutic Categories and Regional Markets Based on
Prescription Data from 420 Hospitals in 22 Major Cities  36
Analysis of Anti-Cancer Market and Anti-Cancer Drugs  39
Top-Selling Anti-Cancer Drugs by Drug Name and Manufacturers  40
Top-Selling Anti-Cancer Drugs – Plant Alkaloids  42
Top-Selling Anti-Cancer Drugs – Antimetabolite  43
Top-Selling Anti-Cancer Drugs – Alkylating Agents  44
Top-Selling Other Anti-Cancer Drugs  45
Analysis of Markets for Cardiovascular Drugs  46
Top-Selling Cardiovascular Drugs – by Drugs and Manufacturers  47
Top-Selling Cardiovascular – Vasodilators  50
Top-Selling Cardiovascular  – Calcium Antagonists  51
Top-Selling Cardiovascular – Angiotensins  52
Top-Selling Cardiovascular – Blood-Lipid Lowering Drugs  53
Top-Selling Cardiovascular – Anti-Angina Drugs  54
Top-Selling Cardiovascular – Beta Blockers  55
Analysis of Market for Endocrine Drugs  56
Top-Selling Endocrine Drugs – by Companies  57
Analysis of Diabetes Market  58
Current Treatment Paradigm for Diabetes Has Many Options  58
Current Insulin Market Size in China is ~Rmb3.5bn  59
Insulin Market Is Dominated by Novo Nordisk  60
Premixed Products Are Better Sellers in the Chinese Market  61
Marketed Insulin Products in China  62
Annual Costs of Insulin Ranges from Rmb1,300 to Rmb11,000  63
Top-Selling Endocrine Drugs – Oral Antidiabetic  64
Top-Selling Endocrine Drugs – Insulin  65
Top-Selling Endocrine Drugs – Hypothalamic Hormone  66
Analysis of the An tibiotics Market  67
Antibiotics Is the Largest Drug Class in China’s Pharmaceutical
Market  67
Antibiotics Classes  68
Breakdown of Antibiotics Market  69
Antibiotics Drug Classes  70
Antibiotics – Top-Selling Drugs  71
Antibiotics – Leading Pharma Companies  72
Top-Selling Antibiotics – Cephalosporin  73
Top-Selling Antibiotics – Benzylpenicillin  74
Top-Selling Antibiotics – Quinolone  75
Top-Selling Antibiotics – Other Lactams  76
Top-Selling Antibiotics – M acrolide and Lincosamides  77
Top-Selling Antibiotics – Anti-Hepatitis B Drugs  78
Biologics – Shining Stars with Strong Growth Potential  79
Top-Selling Biologics – Monoclonal Antibodies  80
Top-Selling Biologics – Recombinant Interferons  81
Top-Selling Biologics – Recombinant Interleukins  82
Analysis of Market for Blood and Hematopoietic System Drugs  83
Top-Selling Blood and Hematopoietic System Drugs –
Intravenous Infusion  84
Top-Selling Blood and Hematopoietic System – Anticoagulants  85
Top-Selling Blood and Hematopoietic System – Antianemic  86
Analysis of Markets for Digestive System Drugs  87
Top-Selling Digestive System Drugs and Manufacturers  88
Top-Selling Digestive System Dr ugs – Proton Pump Inhibitor  89
Top-Selling Digestive System Drugs – Hepatopathy  90
Top-Selling Digestive System Drugs – Antiemetic  91
Analysis of Markets for Central Nervous System Drugs  92
Top-Selling Central Nervous System Drug Names  93
Leading Central Nervous System Drug Companies  94
Top-Selling Central Nervous System – Other Nervous System
Drugs  95
Top-Selling Central Nervous System Drugs – Cerebrovascular  96
Top-Selling Central Nervous System Drugs – Dementia  97
Top-Selling Central Nervous System Drugs – Analgesics  98
Top-Selling Central Nervous System Drugs – Antiparkinsonism  99
Analysis of Markets for Immunomodulator Drugs  100  
Top-Selling Drugs for Immunostimulant  101  
Top-Selling Drugs for Immunosuppressant  102  
Analysis of Markets for Respiratory System Drugs  103  
Leading Respiratory System Drug Companies  104  
Top-Selling Drugs for Respiratory System – Expectorant  105  
Top-Selling Drugs for Respiratory  System – Antasthmatic Inhalant  106  
Top-Selling Drugs for Respiratory System – Antasthmatic  107  
Analysis of Market for Mental Disorder Drugs  108  
Top-Selling Mental Disorder Drugs – Antidepressant  109  
Top-Selling Mental Disorder Drugs – Antipsychotic Drugs  110  
Top-Selling Mental Disorder Drugs – Sedative  111  
Analysis of Markets for Urinary System Drugs  112  
Drug Distribution Industry  113  
With Multiple Layers, China’s Drug Distribution System Lacks
Efficiency  113  
Drug Distribution Value Chain  114  
Industry Is Gravitating Towards Large Players  115  
The Pharmaceutical Markets in the US, EU and Japan Have
Been Increasingly Consolidated  116  
Competitive Landscape in Drug Distribution  118  
Drugstore Overview  119  
China Medical Equipment and Devices  120  
Industry Sales y/y Growth Slowed in 2010  121  
Patient Monitoring Devices  122  
Global PMD Markets  123  
The U.S PMD Market  124  
China’s Ultrasound Market  125  
China’s Ultrasound Market Is Highly Competitive  126  
Drug-Eluting Stent Market  127  
Domestic Growth Rate for PCI Procedures  128  
More Hospitals/Doctors Will Be Able to Perform PCI surgery  129  
Stent Cost Accounts for Over 60% of PCI Cost  130  
Stent Price Cuts  131  
Reimbursement Policies Favor Domestic Brands  132  
Sales and Marketing Strategies  133  
Stent Market Shares by Key Players  134  
Overview of DES Pipeline  135  
Global Orthopedic Market  136  
Chinese Orthopedic Market  137  
Breakdown of Chinese Trauma and Spine Market  138  
Dialysis Market  139  
Expecting the Number of Maintenance Dialysis Patients to Grow  139  
Competitive Landscape in the Dialyzer Market in China  140  
Kidney Dialysis Is a Growing Market  141  
Dialysis Centers Are Getting Crowded  142  
China Contract Research Organization (CRO)  143  
Key Players and Value Chain in China’s Contract Research
Organization (CRO) Market  143  

China vs. India – Split Opinion  144  
China and India CRO: Dragon vs. Elephant?  145  
Comparison of Outsourcing Environment for China vs. India  146  
Deep Dive into China’s CRO Market  147  
Citi Estimate of Outsourcing Ma rket in China (US$ millions)  148  
Toxicology Outsourcing Facing Numerous Hurdles  149  
Global R&D Spending Outlook  150  
Global R&D Spending  151  
Citi R&D Outsourcing Survey  152  
Survey Suggests That 10-20% of the Total R&D Work Is
Outsourced  154  
Appendix A-1  160